製品名:(4-nitrophenyl)-piperazin-1-yl-methanone

IUPAC Name:1-(4-nitrobenzoyl)piperazine

CAS番号:72141-41-4
分子式:C11H13N3O3
純度:95%+
カタログ番号:CM388879
分子量:235.24

包装単位 有効在庫 価格(USD) 数量
CM388879-1g in stock ɅŴ
CM388879-5g in stock ƀȬŴ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:72141-41-4
分子式:C11H13N3O3
融点:-
SMILESコード:O=[N+]([O-])C1=CC=C(C=C1)C(=O)N2CCNCC2
密度:
カタログ番号:CM388879
分子量:235.24
沸点:
MDL番号:
保管方法:

Category Infos

Piperazines
Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

Column Infos

Mitapivat
Jan. 03 2024, Agios announces Phase 3 ENERGIZE study of PYRUKYND (Mitapivat) met primary endpoint and both key secondary endpoints in adults with non-transfusion-dependent(NTD) alpha- or beta-thalassemia. The positive data showed Mitapivat’s potential to become the first oral therapy approved for NTD thalassemia.
Mitapivat is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the US, and for the treatment of PK deficiency in adult patients in the EU. By activating and stabilizing mutant pyruvate kinase, Mitapivat targets the underlying enzymatic defect that causes chronic hemolysis and ineffective erythropoiesis in order to restore enzyme activity.

Related Products